Frankfurt - Delayed Quote EUR

Coherus BioSciences, Inc. (8C5.F)

Compare
1.0195
-0.0045
(-0.44%)
At close: March 3 at 6:59:04 PM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
304,340
257,244
211,042
326,551
475,824
Cost of Revenue
168,262
158,992
70,083
57,591
37,667
Gross Profit
136,078
98,252
140,959
268,960
438,157
Operating Expense
274,404
301,451
397,839
532,818
281,838
Operating Income
-138,326
-203,199
-256,880
-263,858
156,319
Net Non Operating Interest Income Expense
-32,431
-40,542
-32,474
-22,959
-21,166
Other Income Expense
170,307
5,469
-2,400
-283
554
Pretax Income
-450
-238,272
-291,754
-287,100
135,707
Tax Provision
--
-380
--
--
3,463
Net Income Common Stockholders
-450
-237,892
-291,754
-287,100
132,244
Average Dilution Earnings
--
--
--
--
3,307
Diluted NI Available to Com Stockholders
-450
-237,892
-291,754
-287,100
135,551
Basic EPS
-0.05
-2.53
-3.76
-3.81
1.85
Diluted EPS
-0.09
-2.53
-3.76
-3.81
1.62
Basic Average Shares
113,651.6270
94,162.6370
77,630.0200
75,449.6320
71,411.7050
Diluted Average Shares
122,876.8480
94,162.6370
77,630.0200
75,449.6320
83,491.8980
Total Operating Income as Reported
-138,326
-203,199
-256,880
-263,858
156,319
Total Expenses
442,666
460,443
467,922
590,409
319,505
Net Income from Continuing & Discontinued Operation
-450
-237,892
-291,754
-287,100
132,244
Normalized Income
-164,466
-237,892
-285,532
-287,100
132,244
Interest Expense
32,431
40,542
32,474
22,959
21,166
Net Interest Income
-32,431
-40,542
-32,474
-22,959
-21,166
EBIT
31,981
-197,730
-259,280
-264,141
156,873
EBITDA
37,287
-193,939
-255,581
-260,687
159,761
Reconciled Cost of Revenue
168,262
158,992
70,083
57,591
37,667
Reconciled Depreciation
5,306
3,791
3,699
3,454
2,888
Net Income from Continuing Operation Net Minority Interest
-450
-237,892
-291,754
-287,100
132,244
Total Unusual Items Excluding Goodwill
164,016
--
-6,222
--
--
Total Unusual Items
164,016
--
-6,222
--
--
Normalized EBITDA
-126,729
-193,939
-249,359
-260,687
159,761
Tax Rate for Calcs
--
0
--
--
0
12/31/2020 - 11/22/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6XY.F HBM Holdings Limited
0.6450
+4.88%
 
CRO.BE Open Orphan PLC
0.1990
0.00%
 
8JD.F Valbiotis SA
1.2760
+1.11%
 
OPORF hVIVO plc
0.2400
-31.43%
 
CRO.F hVIVO plc
0.1740
+4.82%
 
HPHA.F Heidelberg Pharma AG
2.6300
-5.73%
 
GBM.F Inovio Pharmaceuticals, Inc.
1.8800
+1.62%
 
2LB.F Iovance Biotherapeutics, Inc.
3.8710
-2.32%
 
26CA.F ImmunityBio, Inc.
2.6970
-14.30%
 
1VT.F Viking Therapeutics, Inc.
24.73
-11.36%